Screening compound: InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H

Screening compound: InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H
Screening compound: InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C239-0708

Molecular Formula

C19H13Cl2N3O (C19 H13 Cl2 N3 O)

Compound Name

4-{6-chloro-3-[(4-chlorophenyl)amino]imidazo[1,2-a]pyridin-2-yl}phenol

IUPAC name

4-{6-chloro-3-[(4-chlorophenyl)amino]imidazo[12-a]pyridin-2-yl}phenol

SMILES

Oc(cc1)ccc1-c1c(Nc(cc2)ccc2Cl)n(cc(cc2)Cl)c2n1

InChI

InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H

InChI Key

MPNLGWHSBCBXMC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08682420

InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Antiviral Annotated Library (21441 compounds)

Human Proteases Annotated Library (2868 compounds)

Protein-Protein Interaction Library (218420 compounds)

Selective Target Activity Profiling Library (14702 compounds)

SmartTM Library (51161 compounds)

Carbonic Anhydrase II Library (4939 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
Mechanism of action:
  • Epigenetic
  • PPI modulators

References: we are preparing a list of scientific research reports with InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H?
Check Price and Availability of InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C19H13Cl2N3O/c20-13-3-6-15(7-4-13)22-19-18(12-1-8-16(25)9-2-12)23-17-10-5-14(21)11-24(17)19/h1-11,22,25H available by request